Contact Us
Drug Search Results
More Filters [+]

Zalutumumab

Alternative Names: zalutumumab
Latest Update: 2024-07-11
Latest Update Note: News Article

Product Description

Mechanisms of Action: EGFR Antagonist

Novel Mechanism: No

Modality: Antibody

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Genmab
Company Location: 1253 COPENHAGEN K G7 00000
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Zalutumumab

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Squamous Cell Carcinoma|Head and Neck Cancer

Phase 2: Head and Neck Cancer|Squamous Cell Carcinoma|Colorectal Cancer|Non-Small-Cell Lung Cancer

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
2006-7041-83/hah

N/A

Not yet recruiting

Bone Cancer|Multiple Myeloma

2021-09-01

DAHANCA 19

P3

Completed

Squamous Cell Carcinoma|Head and Neck Cancer

2012-10-31

DAHANCA 19

P3

Completed

Squamous Cell Carcinoma|Head and Neck Cancer

2012-07-01

Zalutumumab PK in SCCHN

P2

Terminated

Squamous Cell Carcinoma|Head and Neck Cancer

2012-06-15

Recent News Events

Date

Type

Title

07/11/2024

News Article

 Head and Neck Cancer Treatment Market size is set to grow by USD 7.12 billion from 2024-2028, Increasing incidence of head and neck cancers boost the market, Technavio

09/15/2022

PubMed

 Comparison of Second-Line Treatments for Patients with Platinum-Resistant Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Systematic Review and Bayesian Network Meta-Analysis.

01/07/2022

PubMed

 Epidermal Growth Factor Receptor as Target for Perioperative Elimination of Circulating Colorectal Cancer Cells.

04/01/2021

PubMed

 Immune-checkpoint inhibitors versus other systemic therapies in advanced head and neck cancer: a network meta-analysis.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions